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Theantigen receptor that is presenton the surface ofmostTcells isaheterodimer
composed of disulfide-linked ct andS chains, each ofwhich has C andV regions
(see reference 1 for a review) . TheVregion of each fl chain isencodedby noncontig-
uous variable (Vg), diversity (DO), and joining Up) gene segments that are juxta-
posed duringT cell development by the process of somaticrearrangement . To date,
only 22 murine TCR /3 chain V region (Vg) gene segments (20 functional genes
and two VS pseudogenes) have been identified, largely from analysis ofCp" clones
from cDNA libraries (1-3) . A statistical analysis of the first 25 Vp sequencesidentified
(representing 14 independentVp gene segments) yielded amaximumlikelihood es-
timate of 18 forthe maximum number ofVp genes, with a95% one-sided confidence
bound of 30 (4). This estimate, however, is based on the assumption that each of
theVp genes is equally likely to be used, whereas actual gene usagemay be non-
random. In fact, the actual Vp repertoire is affected by at least two mechanisms,
deletion and nonexpression . Examples of gene deletion are the Vs haplotype strains
ofmice, such as SJL, SWR, C57BR, C57L, andAU/SsJ, whichhaveadeletion within
the Vp locus that eliminates 10 contiguous Vp gene segments (5-7) . Examples of
the nonexpression of aVp gene are the instances of clonal elimination ofT cells
bearing a/(3 receptors that are reactive to so-called "superantigens" in combination
with certain H-2 class II molecules (8-14) .
If, in fact, Vp gene usage is nonrandom, then there may exist many Vp genes
that are used at lowfrequencyandhave not been isolated fromcDNA libraries . How-
ever, only one complete new functional Vp gene, Vp17a (15), has been identified
in the last 3 yr. Isolation of another Vp gene, provisionally called Vp18, has been
reported, but only a partial nucleotide sequence of this gene has been published
(16) . We sought to investigate whether there exist yet-undiscovered Vp genes that
are expressed at low frequency and whether there exists a substantial number of
pseudogenes by using a panel ofcosmid clones, spanning the BALB/c Vp gene locus,
that had been previously isolated in our laboratory (6) .
In this paper, we report a novel method for identifyingnew Vp genes and present
details on seven newVp genes . The new method involves probing cloned genomic
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DNA with a VS-specific oligonucleotide instead of screening cDNA with a Cs-specific
probe, thereby circumventing the problem, encountered with screening cDNA, of
low expression of certain functional Vo genes. We report here the discovery of a
new functional V0 gene, V019a, and six pseudogenes, including VS19b, as well as
further studies on the expression of V019. In addition, we present the complete
nucleotide sequence of BALB/c V018, which was isolated from cloned genomic DNA
after probing with a cDNA probe.
Materials and Methods
Mice.
￿
5-wk-old BALB/cJ, C57BL/6J, SJL/J, SWR/J, C57BR/cdj, and C57L/J mice were
obtained from The Jackson Laboratory, Bar Harbor, ME.
Oligonuckotides.
￿
Oligonucleotides, which were used as hybridization probes, sequencing
primers, and polymerase chain reaction (PCR)' primers, were synthesized on a DNA syn-
thesizer (380A; Applied Biosystems, Inc., Foster City, CA).
Screening of Cosmids with a VO-specific Oligonucleotide.
￿
The overlapping cosmid clones span-
ning 330 kb of the Vs locus in BALB/c, along with the restriction map, have been previ-
ously described (6).
Cosmid DNA was digested with restriction endonucleases and separated on a0.7% agarose
gel. The gel was dried, denatured in 0.5 N NaOH, 1.5 M NaCl, neutralized in 0.5 M Tris
(pH 7.6), 0.75 M NaCl, and hybridized at 42°C with a Vs-specific oligonucleotide, called
the CASS oligonucleotide (described in Results and shown in Fig. 1), that had been 5' end
labeled with T4 polynucleotide kinase and .y-[32p]ATP The hybridization solution consisted
of 0.9 M NaCl, 0.18 M Tris (pH 7.4), 12 mM EDTA, 10 mM sodium pyrophosphate, and
2 x Denhardt's solution. After hybridization, gels were washed at room temperature with
5 x SSC (0.75 M NaCl, 0.075 M sodium citrate) and then exposed to film, with an inten-
sifying screen, at -70°C.
Six CASS oligonucleotide-positive restriction fragments that did not contain previously
reported Vs genes were identified (designated by an N, for new, followed by a number) and
subcloned into pBluescribe (Stratagene, LaJolla, CA) to generate the corresponding plasmids
(pNI, pN2, etc.).
DNASequencing
￿
The sequence ofpotential Vs genes in the subcloned CASS oligonucleo-
tide-positive restriction fragments was determined by the chain-termination method (17), as
modified for sequencing double-stranded plasmid DNA with Sequenase DNA polymerase
(United States Biochemical Corp., Cleveland, OH). Initial sequence data were obtained using
the CASS oligonucleotide as sequencing primer; additional sequence data upstream, down-
stream, and on the opposite strand were obtained using sequencing primers derived from
the initial sequence.
Vs18 had been previously localized on the genomic map (6) by hybridization of restricted
cosmid DNA with a Vs18 cDNA probe provided by Dr. P A. Singer (Scripps Clinic and
Research Foundation, LaJolla, CA). For sequencing, a 4-kb Bam HI-Sal I fragment from
cosmid C55 was subcloned into pBluescribe, and the nucleotide sequence of VO18 was ob-
tained by the method of Maxam and Gilbert (18).
Sequence analyses were performed using the Microgenie sequence analysis program
(Beckman Instruments, Inc., Palo Alto, CA).
RNase Protection.
￿
Total cellular RNA from spleen and thymus of 5-wk-old mice of six
different strains was prepared by the guanidinium isothiocyanate method (19).
RNA probes were synthesized according to the protocol from the supplier (Stratagene).
Antisense V#16 RNA was synthesized from a DNA template that consisted of a genomic Xba
I fragment containing 67 by of the intron between the first and second VO exons, 293 by
of the second exon, and -220 by of 3' flanking region. Antisense Vs19 RNA was synthe-
sized from a DNA template that consisted of a genomic Nhe I fragment containing 79 by
' Abbreviation used in this paper . PCR, polymenese chain reaction.LOUIE ET AL.
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of leader exon and adjacent 5' untranslated region, 112 by of intron between the first and
second Va exons, and 285 by of second exon.
RNaseprotection wasperformed accordingto themethod of Melton et al. (20), with minor
modifications as detailed in Anderson et al. (21).
Southern Blot Analysis.
￿
15 l~g ofhigh molecular weight DNA from BALB/c and SJL liver
was digested with restriction endonucleases and separated on a 0.7% agarose gel. The gel
was dried, denatured, and neutralized as described for the screening of cosmids, and then
hybridized with auniformly 32P-labeled probe generated by random hexanucleotide-primed
synthesis by the Klenow fragment of Escherichia coli DNA polymerase I in the presence of
a-["P]dCTP (22).
The VgN3 probe was a 283-bp Nhe I-Nco I fragment from pN3, containing almost the
entire second exon (which encodes a few amino acids of the leader peptide and all amino
acids of the mature VS polypeptide segment). The VON1 probe was a 410-bp Bsm I-Hpa
I fragment from pNl, containing the entire second exon, -40 by of upstream intron, and
-90 by of 3' flanking sequence.
Gels were hybridized at 65'C in 5x SSC, 5x Denhardt's solution, 10 mM sodium
pyrophosphate, and 100p,g/ml sheared, denaturedsalmon sperm DNA. Afterhybridization,
gels were washed with 2x SSC (0.3 M NaCl, 0.03 M sodium citrate) at 65°C and then ex-
posed to film, with an intensifying screen, at -70°C.
Cloningof Vg19from SJL by thePCR.
￿
PCRwas performed according to theprotocol sup-
plied by Perkin-Elmer Cetus (Norwalk, CT). 1 hg of high molecularweight DNA from SJL
liver wassubjected to 30 cycles ofPCR in a totalvolume of 100pl, containing 50 mM KCI,
10 mM Tris (pH 8.3), 1.5 MM MgC12, 1.5 mM of each dNTP, gelatin at 100 Icg/ml, N1 jug
of each primer, and 5 Uof Taq polymerase (Perkin-Elmer Cetus). Except for thefirst cycle,
which included a prolonged 5-min denaturation step, and the last cycle, which included a
prolonged 5-min polymerization step, the intervening 28 PCRcycles consisted of denatura-
tion at 90°C for 1.5 min, annealing at 55°C for 1 min, and polymerization at 70°C for 2
min. The PCR product was cloned into the Sma I site of pBluescribe, and plasmid DNA
was sequenced as described above.
Initially, a 5' primer (PCR N3-5a), containing sequence upstream of the BALB/c Vp19
leader, and a 3' primer (PCR N3-3a), containing sequence close to the 3' end of the second
exon, were used to obtain an amplified fragment including the first (leader) exon and most
of the second exon; three independentclones containing this fragment were sequenced. Sub-
sequently, another5' primer (PCR N3-5b), containing sequence upstream of the leader, and
another 3' primer (PCR N3-3d), containing sequence in the 3' untranslated region, were
used to obtain alarger amplified fragment containing all of both V0 exons; one clone con-
tainingthis fragment was sequenced. Thesequencesoftheprimers areas follows: PCRN3-5a:
5'-GAAGAATTCATTGTGTATGAGAAGGTAGCCTAAG-3; PCR N3-3a:5'-AGAGAATTC-
ATCTGTTAGCTTGCTGGACTGGATC-3; PCR N3-5b: 5'-GAAGAATTCACCTTCAG-
AGAAGACAGCTAGCTGA-3'; PCR N3-3d: 5'-AGAGAATTCGCTGATCAGCACTCT
CTTGCTTCTT3.
Results
Design ofa Vg-speck Oligonucleotide.
￿
To design a Vo-specific oligonucleotide that
could be used to screen cloned genomic DNA for new Vg genes, we examined the
amino acid sequences encoded by the known VS genes for amino acid stretches that
are highly conserved. It wasnoted that 14 of the 19 V0 genes that had been identified
by the beginning of this studyencoded Tyr-Phe/Leu-Cys-Ala-Ser-Ser as the last six
COOH-terminal amino acids (Fig. 1). From an examination of the nucleotide se-
quence that encodes these six amino acids, we arrived at a fourfold degenerate 18-
mer (CASS oligonucleotide) that is the inverse complement of the coding sequence
(Fig. 1).
Identification ofNew VS Genes.
￿
Southern analysis of restricted DNA from a series1990
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Derivation of the nucleotide sequence of the CASS oligonucleotide. (Line 1) The
amino acid sequence encodedby the Tend of 14 of 19 V,p gene segments. (Line 2) The nucleo-
tide sequence encoding the abovesixaminoacids. (Line 3) The frequencyofbase usage, tabu-
lated from an examination of 19 different V0 sequences, at each of the 18 nucleotide positions
shown in line 2. (Line 4) The sequence of the CASS oligonucleotide; the inverse complement
of the sequence shown in line 2.
of cosmid clones spanning the VS locus (including a series of overlapping cosmids
encompassing the 330-kb region containing 20 of the previously identified Vas genes,
two overlapping cosmids containing V#2, and two contiguous cosmids containing
C01, C#2, and Vg14) yielded six CASS oligonucleotide-positive restriction fragments
(designated by the prefix N in Fig. 2) that did not contain one of the known VO
genes. A detailed map showing restriction sites and cosmids has been previously
published (6).
Two of the CASS oligonucleotide-positive fragments, N8 and N9, are located in
the 55-kb gap between Vs1 and Vs5.2. Two other fragments, N3 and N1, are lo-
cated upstream and downstream, respectively, of V017b.
Nucleotide and PredictedAminoAcidSequences ofthe New Yo Genes.
￿
Two criteria that
were used to assess whether a sequence is that of a Vs gene are the presence of
heptamer-nonamer recombination signals downstream of the second exon and the
presence, in thepredictedamino acid sequence, ofthe sixaminoacids that are abso-
lutely conserved in all Vg genes discovered to date.
The nucleotide sequences of putative Vo genes in the CASS oligonucleotide-
positive fragments are shown in Fig. 3. Five of the six new CASS oligonucleotide-
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Map of a portion of the BALB/c Vo locus, showing the location of six CASS
oligonucleotide-positive restriction fragmentsthat do notcontain knownVp genes. TheV# genes
areindicatedby vertical linesabovethehorizontal line. CASS oligonucleotide-positive restriction
fragmentsnot containing known VS genes are depicted by solid bars underthe horizontal line
andare designated by N(for new),followed by anumber.Adetailed mapshowingtherestriction
sites and the cosmid clones spanning this region of the genome has been previously published
(6). Nl is a 1.5-kbKpnI-EcoRI fragment containedwithin the8-kb Barn HI fragment ofcosmid
D18. N2 is a1.1-kbBarn HI fragment from cosmid D18. N3 isa7-kbKpnIfragment from cosmid
B2, which has an insert that is almost the same as that of cosmid B47. N5 is a 6-kb Kpn I-Sal
I fragment from cosmid B47. N8 is a 2.4-kb Kpn I fragment from cosmid B41. N9 is a 4-kb
Kpn I-Bam HI fragment from cosmid C47.1 001
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Nucleotide sequence of theputative newV0 genesin thesix CASS oligonucleotide-
positive restriction fragments. The putative newVp genes are named afterthe restriction frag-
ments in which they lie. Initial sequence was obtained using the CASS oligonucleotide as se-
quencing primer; additional sequence upstream, downstream, and on the opposite strand was
obtained with oligonucleotide primers derived from theinitial sequence. The various sequences
were aligned by firstaligning the nucleotides encoding theinvariant aminoacids, whichareshown
(boldfaced) above the nucleotide sequence. Nucleotides are numbered accordingto Patten et al.
(23),with position 1 beingthefirstbase ofthecodon specifying the firstaminoacid ofthemature
V0 polypeptide segment aftercleavage oftheleader peptide. The sequence that hybridized with
theCASS oligonucleotideis boxed.Putative heptamer andnonamerrecombinationsignalsdown-
stream of the protein-coding region areunderlined anddenotedby 7and9, respectively. Dashes
within the sequence indicate gaps that have been introduced to maximize homology. Shown in
the last line is the sequence of V018, a gene for which a partial nucleotide sequence has been
previously published (16). These sequence data have been submitted to the EMBL/GenBank
Data Libraries under the accession numbers X16689-X16695.
positive genes contain heptamer and nonamer recombination signals downstream
ofthe protein-coding sequence. The exception, VON1, has aheptamer-like sequence,
CACAATC, somewhat farther downstream than the heptamer found in other V0
genes, but no nonamer-like sequence 23 by downstream. The transcriptional orien-
tation ofall six newCASS oligonucleotide-positivegenes is thesame as that ofprevi-
ously identified V0 genes in the contiguous 330-kb genomic region screened.
The Amino acid sequences (Fig. 4) predicted by the nucleotide sequences were
also examined to determine whether the encoded amino acids were characteristic
of a V0 polypeptide segment. Three of the six new V,p genes (VSN3, VON8, and
VpN9) have identifiable invariant amino acids in a single reading frame; thus, the
aminoacidsequence presentedin Fig. 4 isthatpredicted bythe nucleotide sequence
ofthe single reading frame. The other three newCASS oligonucleotide-positive V0
C-CATCTTOG~"CMS-CAOAAOC"-T-ACTT
CCTGCAGRTOG~TCAO"CRCTGMGRGGMARCAGTGTT
ACSTCMMCCAOCM
ACCTCTG?G-GCM
CMAAATATGMCTRACTTTGtOCACMTCCRATATGTAOTG
GTC---GCAGGTSO~TYSGTGTTOYCTTTMCAGCWCT
CATGTACCATAO~TCCMTC~~MM-ATTCAOCSGT ACSTCTGMCTAO~ MTC--GCAGTGGMACTACTOGCTTTTRCAGAACAGAAACTC
CCCAACATCCTAAAOT0000C~CAOATCM~ATOCAOAGCT ACTTCTGTOCOAORC CCCT--GCATT~TACTTCTMATOTTTTRGCCTT~~
TCTCCATGT'TG~AGCCMTOAACACATCMOMGACTTA00CAT
TCCC~ACATTMAOTCMC~"C--CMCCMACR--CCA
ATCTCTGTGCCMMG
ACSTCTGGYCGUCAO
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FIGURE 4.
￿
Amino acid sequences of the six putative new CASS oligonucleotide-positive VS
genes. The aminoacidsaredenotedby the single-letter code. The various aminoacid sequences
are aligned by the six amino acids that are invariant in the Vg genes identified to date; these
six invariant amino acidsare shown(boldfaced) abovethesequences. ForthoseVA genes(VON3,
VpN8, andV#N9)that have the invariant amino acids in a single reading frame, theamino acid
sequence shown is that predicted by the nucleotide sequence of the single reading frame. For
thoseV,6genes(VONI, VON2, andV,gN5) that have theinvariant aminoacidsin multiple reading
frames, the sequence shown is a "best-fit" amino acid sequence; the transition region between
two reading frames, where a definite amino acid sequence cannot be deduced, is indicated by
one or more plus signs. A dash within a sequence indicates a gap that has been introduced to
optimize alignment. An asterisk indicates the position corresponding to a termination codon.
genes (VSNI, VSN2, and VsN5) have identifiable invariant amino acids in multiple
reading frames, presumably due to nucleotide insertions and/or deletions; there-
fore, the amino acid sequence presented in Fig. 4 is a "best-fit" sequence, with a
plus sign indicating thetransition between tworeadingframes, whereaspecific amino
acid sequence cannot be deduced.
VSN1 and VON5 contain duplicated nucleotide stretches that disrupt the reading
frame. The duplication in VsN1 includes the proline residue at position 8 that is
absolutely conserved in all previously reported VS genes; in addition, VSN1 is
missing one of the two invariant cysteine residues. The duplication in VON5 results
in a duplication of the conserved tryptophan and tyrosine residues at positions 36
and 37; VON5 is also missing oneofthe two invariant cysteinesand contains at least
six termination codons. VRN8 contains three termination codons and is missing the
conserved tryptophan residue at position 36. VsN2, which contains at least two ter-
mination codons, is identical to a pseudogene, Vp3.30, which had been identified
earlier in our laboratory by crosshybridization with a V,g3 probe.
Twoof the new oligonucleotide-positive genes, VsN3 andVON9, have open reading
frames. VON9, however, contains neither of the conserved cysteine residues that are
presumably involved in the intrachain disulfide bond. Thus, on thebasisof sequence
alone, five of the six new CASS oligonucleotide-positive genes cannot encode func-
tional Vg polypeptide segments and are presumably pseudogenes. On the other
hand, the open reading frame of VON3 encodes all six of the amino acids that are
invariant in the previously reported V,0 genes; this potentially functional gene we
call Vs19.
Expression of Vs19.
￿
Because it had an open reading frame that encoded all six
of the amino acids absolutely conserved in functional VS genes, and because it had
heptamer-nonamer recombination signalsdownstream ofthe protein-coding region,
V019 was potentially afunctional gene and was therefore further characterized. To
determine whetherV019 is expressed, we performed RNase protection experiments
usingtotal cellular RNA and an RNA probe encompassing both exons ofV019 (in-
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cluding sequence upstream of the leader exon) and the intervening intron . These
experiments showed that V#19 was not transcribed in the thymus ofBALB/c mice,
the strain from which it was identified, but was transcribed in SJL thymus (Fig.
5 A) . SJL is a Va haplotype strain, in which alarge deletion has eliminated 10 con-
tiguous V,# gene segments, and in which nondeleted V,# genes might be compen-
satorily expressed at increased frequency . RNase protection analysis ofRNA from
another Vs haplotype (nondeletion) strain (C57BL/6) and from three other Vs
haplotype strains (SWR, C57BR, and C57L) confirms thepattern ofexpression found
FIGURE 5 .
￿
RNase protection analysis of Vp19 (VpN3). (A) Autoradiograb ph ofa gelfrom RNase
protection assays usinga Vp19 probe against RNA samples from two Vp haplotype strains and
from four VS haplotype strains of mice . 50 wg of total cellularRNAwasused in each assay . De-
tails about the antisenseRNAprobe are given in Materialsand Methods . As a negative control,
theVS19 probe was assayed against yeasttRNA .The protected fragments are indicated by arrows
labeled with V (for the Vp second exon) and L (for the leader exon and 5' flanking sequences).
P indicates alane in which onlyRNAprobe is loaded . s, spleen ; t, thymus . (B) Level ofexpression
ofVp19 compared with that ofVpl6. As in A, 50 jug of total cellularRNAwas used in each assay .
Details about the Vp19 and Vp16 antisenseRNA probes are given in Materials and Methods.
The protected fragments, corresponding to theVp second exons, are indicated by arrows on the
right side of each panel . The sizes, in nucleotides, of selected fragments of an Msp I digest of
pBR322 areshownon the left side ofeach panel. P, probe only; s, spleen ; t, thymus. (C)Compar-
ison ofVp19 leader sequences from BALB/c and from SJL . ATG (initiation) codons, out-of-frame
in BALB/c and in-frame in SJL, are underlined . The single-base insertion in theSJL sequence
that results in an in-frameATGupstream is indicated by an arrow. Thelowercase letters at the
3' end ofthe sequence are the nucleotides at the 5' end of the intron between the first (leader)
and second Vg exons.1994
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in BALB/c and SJL; that is, absent (or undetectably low) expression in Vb haplo-
type strains and low-level expression in Vs haplotype strains (Fig . 5 A) . Compar-
ison with Vp16, a Vp gene expressed in ti5% of Co-containing clones from an SJL
thymus cDNA library (M . C. Louie, unpublished data) shows that the level of ex-
pression of V019 in SJL thymus is low, considerably less than that ofV016 (Fig . 5 B) .
RNase protection analysis ofRNA from thymus of Va haplotype mice also re-
veals aprotected fragment of-80 nucleotides (Fig. 5A), consistent with protection
oftheportion of theRNA probe corresponding to the leader exon and the adjacent
upstream sequence ofBALB/c Vp19b. Thus, in the Va haplotype strains of mice,
a leader sequence that is identical to, or nearly identical to, the BALB/cVp19bleader
is transcribed .
To investigate whether a difference in the sequences of the Vp19 genes from V0
andVb haplotype mouse strains may account for the difference in expression of the
gene, we cloned the Vp19 gene from SJL genomicDNA by thePCR method, using
oligonucleotide primers corresponding to sequences upstream of the BALB/c Vp19
leader sequence and within or downstream of the BALB/c Vp19 second exon . Com-
parison of the nucleotide sequences of the Vp19 genes from BALB/c and from SJL
revealed that the exon sequences are identical, except for a single-base insertion in
the leader exon of Vp19 from SJL, shifting the reading frame so that there is no
longer an in-frame terminationcodon downstream ofan out-of-frame initiation codon,
as was found in the leader exon of Vp19 from BALB/c, thereby resulting in a leader
exon encoding 19 amino acids (Fig . 5 C) . Thus, in SJL, Vp19 is a functional gene .
Southern Blot Analysis ofVp19.
￿
Southern analysis of genomicDNA from BALB/c
and from SJL showed RFLP at the Vp19 locus for five different restriction en-
donucleases (Fig. 6). Similarly, the VpNl locus in BALB/cand in SJL showed RFLP
for Eco RI, Hind III, and Bgl II (data not shown) . Genomic DNA prepared from
the tails of mice of the six strains used in the RNase protection experiments (Fig .
5 A) and hybridized with the Vp19 second exon probe showed two-allele RFLP for
FIGURE 6 .
￿
Southern blot analysis oftotal genomic DNA from
BALB/c and from SJL . 15 Rg of high molecular weight DNA
prepared from BALB/c or SJL liver was digested with the re-
striction enzymes indicated, and the DNA was separated on
a 0.7% agarose gel. The dried and denatured gel was hybrid-
ized with a 32P-labeled Vs19 (VpN3) probe ; hybridization and
wash conditions are given in Materials and Methods. Size
markers, in kilobases, are shown at theleft . B, BALB/c; S, SJL .VA genes
￿
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￿
19b
￿
3.30 17b NI0 3 .1
10kb
LOUIE ET AL.
￿
1995
FIGURE 7.
￿
Map ofthe 39-kb region ofDNA bounded by
Vp15 and Vp3.1 that contains two functional Vp genes and
four Vp pseudogenes. The transcriptional orientation ofall
six Vs genes is the same, with the 5' to 3' direction run-
ning left to right on the map. A restriction map of this re-
gion has been previously published (6).
both Kpn I (7 kb in the ,,,,b haplotype mice; 9 kb in the Vs haplotype mice) and
Eco RI (2.1 kb in the Vs haplotype mice; 4.3 kb in the V0 haplotype mice) (data
not shown). A map of this genomic region is shown in Fig. 7.
Discussion
In this paper, we report the nucleotide and amino acid sequences of six new VO
genes that were isolatedby anovel method in whichcloned genomic DNA is probed
with a fourfold degenerate oligonucleotide that is complementary to the nucleotide
sequence encoding six amino acids that are present at the COON terminal of ap-
proximately three fourths ofthe known VS polypeptide segments. Probing genomic
DNA circumvents the difficulty ofcloning genes that are expressed at verylow fre-
quency ina cDNA library. Sinceonly aboutthree fourthsofthepreviously identified
functional VS genes encode a polypeptide segment with Tyr-Phe/Leu-Cys-Ala-Ser-
Ser at the COOH-terminal end, we might expect, by extrapolation, that probing
with the CASS oligonucleotide would fail to identify about one fourth ofthe yet-
unidentified V0 genes.
Five ofthe six CASS oligonucleotide-positive genes are pseudogenes, based on
thepresenceoftermination codons within the coding region orthe absence ofabso-
lutely conserved amino acids, especially one or both ofthe cysteine residues that
form the intrachain disulfide bond. Several of the new genes contain obvious
frameshifts, suggestingthe insertionordeletion ofoneormore nucleotides. Neverthe-
less, based on the presence of other absolutely conserved amino acids and on the
presence of heptamer and nonamer recombination signal sequences downstream
ofthe protein-coding sequence, the newly identified genes are clearly recognizable
as V0 gene segments.
Because only two ofthe first 22 V0 genes were pseudogenes, it was concluded that
V0 pseudogenes are relatively rare. Incontrast, the frequency ofpseudogenes among
Ig V genes is ^+30% (24). Here, however, we report the discovery of six new V0
pseudogenes, indicating that V0 pseudogenes are much more abundant than previ-
ously thought. An examination ofthenucleotide sequences ofthese six pseudogenes
revealsthatthe presentnucleotide sequences can bederived from sequencesencoding
all six ofthe amino acids that are absolutely conserved amongknown VS gene seg-
ments by simple (often single-nucleotide) substitutions, insertions, ordeletions. The
pseudogenesthat havebeen identified to datefall intotwo classes: pseudogenes (such
as V#17b and V019b) with point mutations, and pseudogenes with more extensive
mutations involvingmultiple regions ofthe coding sequences. The observation that
all six ofthe new CASS oligonucleotide-positive V,6genes inBALB/care pseudogenes
is more consistent with the hypothesis that the functional Ve repertoireis small and
that most ofthe functional V0 genes have already been cloned than with the notion
that the functional V0 repertoire is large, with many VS genes used infrequently.1996
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Two of the new pseudogenes, VsN1 and VsN2 (Vg3.30), are located in the rela-
tively crowded genomic region bounded by VS15 and V03.1, where two functional
V,0 gene segments and four Vg pseudogenes are located within 39 kb of DNA (Fig.
7). Further analysis ofthe nucleotide sequences (Fig. 3) reveals that these clustered
genes are highly homologous. Not unexpectedly, the second and third members of
the V03 subfamily (Vp17b and V03.30) are both 74% identical, at the nucleotide
level, to Vp3.1. VONI is slightly less homologous (66-68% identical at the nucleo-
tide level) to the three members of the V03 subfamily. V#19b is even less homolo-
gous (64-65% identical at the nucleotide level) to the V03 subfamily members and
only 57% identical to VON1. The extensive homology amongthese genes makes pos-
siblethe process ofrecombination by homologous but unequalcrossing over. Though
the molecularmechanism andthe specific sequence requirements ofthe recombina-
tion process are largely unknown, the extensive RFLP noted for V019 and VONI
(this paper), and for V017 (15), supports the notion that this region of highly ho-
mologous pseudogenes is the site of an increased rate of recombination. Interest-
ingly, a newly described Vs deletion has its 3' boundary in this region (25).
The RFLP at the V019 locus in the Vs andVb haplotype mouse strains is analo-
gous to that previously reported for V017 (15). In keeping with the nomenclature
established with VR17 (3, 15), we call V019a the allele that is present in Vq haplo-
type mouse strains and V019b the allele that is present in Vb haplotype strains.
RNase protection experiments reveal that a leader sequence identical to, or nearly
identical to, the leader sequence from BALB/c, aVb haplotype strain, is indeed tran-
scribed (and presumably correctly spliced to a V019a second exon) in the Vahaplo-
type mice. Thus, the expression of V019a does not appear to involve alternative
splicing ofthe transcripts from the second exon of V019a and from the intact leader
exon of another Vp gene, as has been reported with the alternative splicing of the
transcripts from the second exon of V08.2 and from the leader exon of VS5.1, a gene
located -2 .5 kb upstream of V08.2 (2).
It has been shown that T lymphocytes expressing Vp17a are clonally eliminated
in mouse strains, such as C57BR, that express an I-E class II MHC molecule (5,
14, 15). New gene V#19 was expressed in all four V' haplotype strains examined
and not expressed in both Vs haplotype strains examined. By analogy, if Vs19a-
carrying strains that do not express V#19a can be found, one might investigate
whether VS19a is clonally eliminated because of reactivity to a self-antigen expressed
in these strains.
Summary
By screening previously isolated genomic clones spanning the mouse TCR VS
locus with Vo-specific oligonucleotides, we have isolated one new functional VS gene
and six V0 pseudogenes. Because this method of identifying new genes does not de-
pend on expression levels, we conclude that most, if not all, VAS genes in the mouse
have been identified. The newly identified pseudogenes increase the frequency of
mouse TCR Vp pseudogenes to 28%, afrequency similar to that estimatedfor mouse
Ig V pseudogenes (24).
Three of the newly discovered pseudogenes are clustered in a region around an-
other pseudogene (Vo17b). The extensive DNA diversity, as reflected in both thenucleotide sequence and the RFLP, indicates that this genomic region is a possible
hotspot of recombination.
The new functional gene, Vp19a, is expressed at very low levels, which explains
why it has not been isolated earlier. Vs19 shows expression patterns that correlate
with the previously described V~ and Vs haplotypes.
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